SMPD3 and ovarian carcinoma: Similarly, GW4869, a neutral sphingomyelinase 2 (nSMase2) inhibitor, reduced exosome secretion, reversing chemoresistance in colorectal, pancreatic, and ovarian cancer cells [151,152,153].